We are live on ! Find out more
JNJ icon

Johnson & Johnson

3,869 hedge funds and large institutions have $269B invested in Johnson & Johnson in 2023 Q4 according to their latest regulatory filings, with 373 funds opening new positions, 1,301 increasing their positions, 1,882 reducing their positions, and 125 closing their positions.

New
Increased
Maintained
Reduced
Closed

198% more first-time investments, than exits

New positions opened: 373 | Existing positions closed: 125

19% more call options, than puts

Call options by funds: $3.25B | Put options by funds: $2.73B

5% more funds holding

Funds holding: 3,6793,869 (+190)

2.15% more ownership

Funds ownership: 69.2%71.36% (+2.2%)

4% more capital invested

Capital invested by funds: $260B → $269B (+$9.6B)

20% less funds holding in top 10

Funds holding in top 10: 370295 (-75)

31% less repeat investments, than reductions

Existing positions increased: 1,301 | Existing positions reduced: 1,882

Holders
3,869
Holders Change
+190
Holders Change %
+5.16%
% of All Funds
56.4%
Holding in Top 10
295
Holding in Top 10 Change
-75
Holding in Top 10 Change %
-20.27%
% of All Funds
4.3%
New
373
Increased
1,301
Reduced
1,882
Closed
125
Calls
$3.25B
Puts
$2.73B
Net Calls
+$518M
Net Calls Change
+$67.9M
Name Holding Trade Value Shares
Change
Change in
Stake
TI
3876
Trexquant Investment
Connecticut
-$23.8M -153,116 Closed
AC
3877
Armistice Capital
New York
-$20.9M -134,378 Closed
Point72 Asset Management
3878
Point72 Asset Management
Connecticut
-$19.4M -126,420 Closed
GCM
3879
Ghisallo Capital Management
Massachusetts
-$15.6M -100,000 Closed
EW
3880
Evoke Wealth
California
-$15.1M -97,070 Closed
Holocene Advisors
3881
Holocene Advisors
New York
-$9.4M -60,372 Closed
PWP
3882
Perfromance Wealth Partners
Illinois
-$8.27M -53,086 Closed
BCM
3883
Bayesian Capital Management
New York
-$7.99M -51,300 Closed
MIM
3884
Martin Investment Management
Florida
-$6.78M -43,525 Closed
Arrowstreet Capital
3885
Arrowstreet Capital
Massachusetts
-$6.47M -41,553 Closed
YIH
3886
Y-Intercept (HK)
Hong Kong
-$6.23M -40,006 Closed
CAC
3887
Cowen and Company
New York
-$5.84M -37,500 Closed
PL
3888
Parkwood LLC
Ohio
-$5.54M -35,573 Closed
BWM
3889
Bulltick Wealth Management
Florida
-$5.47M -35,095 Closed
FMAEN1
3890
Fund Management at Engine No 1
California
-$5.36M -34,440 Closed
STC
3891
Sarah T. Connolly
-$4.86M -31,230 Closed
FI
3892
Fosun International
China
-$4.75M -30,476 Closed
CIAS
3893
CFS Investment Advisory Services
New Jersey
-$4.68M -30,064 Closed
AAM
3894
Alphadyne Asset Management
New York
-$3.86M -24,772 Closed
IPW
3895
IronBridge Private Wealth
Texas
-$3.78M -24,280 Closed
LBC
3896
Lawrence B. Cohen
-$3.22M -20,679 Closed
MLM
3897
Mount Lucas Management
Pennsylvania
-$2.53M -16,273 Closed
SFCL
3898
Strengthening Families & Communities LLC
Massachusetts
-$2.37M -15,243 Closed
Gates Foundation Trust
3899
Gates Foundation Trust
Washington
-$2.33M -14,945 Closed
VFM
3900
Viking Fund Management
North Dakota
-$2.18M -14,000 Closed

JNJ Hedge Fund Activity: Q4 2023 in Review

3,869 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q4 2023, worth a combined $269B — up 3.7% from $260B a quarter earlier.

Buyers outnumbered sellers: 373 funds opened new JNJ positions and 125 closed out — a net gain of 248 holders — while 1,301 added to existing stakes and 1,882 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $6.45B. The largest seller was Bank of America, cutting an estimated $406M.

  • 3,869 institutional investors held Johnson & Johnson (JNJ) as of Q4 2023, up from 3,679 in Q3 2023.
  • Funds reported $269B of Johnson & Johnson stock for Q4 2023, up 3.7% quarter-over-quarter.
  • 373 funds opened new Johnson & Johnson positions in Q4 2023 and 125 closed out, a net change of +248 holders.
  • The largest Johnson & Johnson buyer in Q4 2023 was Morgan Stanley, an estimated $6.45B added.
  • The largest Johnson & Johnson seller in Q4 2023 was Bank of America, an estimated $406M sold.

Based on aggregated 13F filings for Q4 2023.